NUP214 anticorps (AA 28-238)

N° du produit ABIN7161840

L’anticorps Lapin Polyclonal anti-NUP214 a été validé pour ELISA, IHC et IF. Il convient pour détecter NUP214 dans des échantillons de Humain.

Aperçu rapide pour NUP214 anticorps (AA 28-238) (ABIN7161840)

Antigène: NUP214 (Nucleoporin 214kDa (NUP214))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp NUP214 est non-conjugé

Application: ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)

Détail du produit anti-NUP214 anticorps

Épitope: AA 28-238

Réactivité croisée: Humain

Purification: >95%, Protein G purified

Immunogène: Recombinant Human Nuclear pore membrane glycoprotein 210 protein (28-238AA)

Isotype: IgG

Information d'application

Indications d'application: Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C,-80 °C

Stockage commentaire: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Détails sur NUP214

Antigène: NUP214 (Nucleoporin 214kDa (NUP214))

Autre désignation: NUP21

Sujet:

Background: Nucleoporin essential for nuclear pore assembly and fusion, nuclear pore spacing, as well as structural integrity.

Aliases: FLJ22389 antibody, GP 210 antibody, KIAA0906 antibody, Nuclear envelope pore membrane protein POM 210 antibody, Nuclear pore membrane glycoprotein 210 antibody, Nuclear pore protein gp210 antibody, Nucleoporin 210 antibody, Nucleoporin 210 kDa antibody, Nucleoporin Nup210 antibody, Nucleoporin210 antibody, NUP 210 antibody, Nup210 antibody, PO210_HUMAN antibody, POM 210 antibody, POM210 antibody, Pore membrane protein of 210 kDa antibody

UniProt: Q8TEM1

Pathways: Protein targeting to Nucleus, SARS-CoV-2 Protein Interactome, Phosphorylation & l'infection par le SRAS-CoV-2